Susceptibility of Mink (Mustera vision)-Derived Cells to Replication by Human Immunodeficiency Virus Type 1

ABSTRACT In vivo studies for understanding viral transmission and replication, host immune responses, and pathogenesis of human immunodeficiency virus type 1 (HIV-1) infection would greatly benefit from the establishment of a small-animal model. In this study, we explored the potential of American mink (Mustera vison) as a susceptible host. We found that primary cells and cell lines derived from this species efficiently supported trans-activation of the HIV-1 long terminal repeat by Tat. Accordingly, the cysteine residue at position 261, which has been shown to be important for interaction of the human cyclin T1 with the HIV-1 regulatory protein Tat, is conserved in the mink homologue. No species-specific defect in Rev function could be detected in mink cells. In addition, primary splenocytes, fibroblasts, and the Mv.1.Lu cell line from American mink supported early as well as late HIV-1 gene expression following infection with vesicular stomatitis G protein-pseudotyped HIV-1 viruses, at levels comparable to those seen with permissive human cells. Furthermore, the mink Mv.1.Lu cell line stably expressing human CD4 and CCR5 receptors supported a spreading HIV-1 infection with few, if any, deficiencies compared to findings in human cell lines. This indicates the potential of HIV-1 to replicate in these cells once the blockade at the stage of virus entry has been removed. These results clearly show that cells from American mink generally pose no functional intracellular block to HIV-1 replication, and collectively they raise the possibility that this animal species could be engineered to support HIV-1 infection, providing a useful small-animal model for evaluating de novo infection by HIV-1.

[1]  S. Matsushita,et al.  Ability of small animal cells to support the postintegration phase of human immunodeficiency virus type-1 replication. , 2003, Virology.

[2]  C. Cheng‐Mayer,et al.  Addition of a Single gp120 Glycan Confers Increased Binding to Dendritic Cell-Specific ICAM-3-Grabbing Nonintegrin and Neutralization Escape to Human Immunodeficiency Virus Type 1 , 2002, Journal of Virology.

[3]  M. Goldsmith,et al.  Progress Toward a Human CD4/CCR5 Transgenic Rat Model for De Novo Infection by Human Immunodeficiency Virus Type 1 , 2002, The Journal of experimental medicine.

[4]  T. Greenough,et al.  CD4 Down-Modulation by Human Immunodeficiency Virus Type 1 Nef Correlates with the Efficiency of Viral Replication and with CD4+ T-Cell Depletion in Human Lymphoid Tissue Ex Vivo , 2001, Journal of Virology.

[5]  M. Goldsmith,et al.  Susceptibility of Rat-Derived Cells to Replication by Human Immunodeficiency Virus Type 1 , 2001, Journal of Virology.

[6]  H. Kräusslich,et al.  Mouse-Human Heterokaryons Support Efficient Human Immunodeficiency Virus Type 1 Assembly , 2001, Journal of Virology.

[7]  田原 聡子 Differential level in co-down-modulation of CD4 and CXCR4 primed by HIV-1 gp120 in response to phorbol ester, PMA, among HIV-1 isolates , 2001 .

[8]  B. Cullen,et al.  Multiple Blocks to Human Immunodeficiency Virus Type 1 Replication in Rodent Cells , 2000, Journal of Virology.

[9]  A. Fauci,et al.  Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis , 2000, Immunological reviews.

[10]  H. Nakauchi,et al.  Differential Level in Co‐Down‐Modulation of CD4 and CXCR4 Primed by HIV‐1 gp120 in Response to Phorbol Ester, PMA, among HIV‐1 Isolates , 2000, Microbiology and immunology.

[11]  T. Hope,et al.  A Block to Human Immunodeficiency Virus Type 1 Assembly in Murine Cells , 2000, Journal of Virology.

[12]  B. Cullen,et al.  Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein , 1999, Current Biology.

[13]  D. Trono,et al.  Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner , 1999, Current Biology.

[14]  O. Nishimura,et al.  A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Gaynor,et al.  Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation. , 1999, Journal of molecular biology.

[16]  J. Albert,et al.  Primary Human Immunodeficiency Virus Type 2 (HIV-2) Isolates, Like HIV-1 Isolates, Frequently Use CCR5 but Show Promiscuity in Coreceptor Usage , 1999, Journal of Virology.

[17]  B. Peterlin,et al.  Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[19]  B. Cullen,et al.  Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV‐1 Tat , 1998, The EMBO journal.

[20]  M. Garber,et al.  The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. , 1998, Genes & development.

[21]  M. L. Penn,et al.  Rabbit Cells Expressing Human CD4 and Human CCR5 Are Highly Permissive for Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.

[22]  G. Suzuki,et al.  Disturbed CD4+ T Cell Homeostasis and In Vitro HIV-1 Susceptibility in Transgenic Mice Expressing T Cell Line–tropic HIV-1 Receptors , 1998, The Journal of experimental medicine.

[23]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[24]  C. Raker,et al.  Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Mathews,et al.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.

[26]  D. Hazuda,et al.  P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.

[27]  A. Trkola,et al.  Co-receptors for HIV-1 entry. , 1997, Current opinion in immunology.

[28]  P. Kimmel,et al.  Human chromosome 6- and 11-encoded factors support human immunodeficiency virus type 1 Rev function in A9 cells , 1996, Journal of virology.

[29]  M. Mehtali,et al.  Human immunodeficiency virus type 1 infection of human CD4-transgenic rabbits. , 1995, The Journal of general virology.

[30]  R. Connor,et al.  Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. , 1995, Virology.

[31]  C. Cheng‐Mayer,et al.  HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. , 1994, Immunity.

[32]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[33]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[34]  M. Malim,et al.  Mutational definition of the human immunodeficiency virus type 1 Rev activation domain , 1991, Journal of virology.

[35]  S. Sell,et al.  Syphilis superinfection activates expression of human immunodeficiency virus I in latently infected rabbits. , 1991, The American journal of pathology.

[36]  D. Baltimore,et al.  A human cell factor is essential for HIV‐1 Rev action. , 1990, The EMBO journal.

[37]  L. Bacheler,et al.  Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. , 1989, Science.

[38]  G. Filice,et al.  Infection of rabbits with human immunodeficiency virus , 1988, Nature.

[39]  M. Yaniv,et al.  Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma , 1984, Cell.